| Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome: correlation to cytomorphology, cytogenetics, and clinical data. | |
| | |
MedLine Citation:
|
PMID: 20572043 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: The diagnosis and classification of myelodysplastic syndromes (MDS) is based on cytomorphology (CM) and cytogenetics (CG). Multiparameter flow cytometry (MFC) may add important diagnostic information. METHODS: To evaluate the potential role of MFC in the diagnostic setting of MDS, the authors analyzed the results from 1013 patients with suspected MDS by using CM, CG, and MFC in parallel. RESULTS: Concordance between CM and MFC was 82% for diagnostic results in 788 patients who had unequivocal CM results. An additional 225 patients had only minor dysplastic features identified by CM, including 51 patients (22.7%) who had clear evidence of MDS by MFC. Twelve patients who had no indication of MDS identified by CM had MDS-typical CG aberrations; in 6 of those patients (50%), MFC revealed MDS characteristics. In another 11 of 23 patients (47.8%) who had minor dysplastic features identified by CM and MDS-typical CG aberrations, MFC revealed MDS characteristics. The percentages of blasts determined by CM and by MFC were strongly correlated (P<.001). The frequency of aberrantly expressed antigens differed significantly between patients rated by CM as MDS (highest frequencies), suspected MDS, and no MDS (lowest frequencies). In various patients, MFC identified MDS-typical aberrant antigen expression in cell compartments that were not rated dysplastic by CM. The numbers of aberrantly expressed antigens were correlated with International Prognostic Scoring System scores and overall survival. CONCLUSIONS: The current analysis clearly demonstrated an increased diagnostic yield with MFC when added to CM and CG in patients with suspected MDS. |
| | |
Authors:
|
Wolfgang Kern; Claudia Haferlach; Susanne Schnittger; Torsten Haferlach |
Related Documents
:
|
31123 - Protective environment for marrow transplant recipients: a prospective study. 3533293 - Chromosomal changes in secondary leukemias of childhood and young adulthood. 2216293 - Cerebrospinal fluid content of manganese, platinum, and strontium in patients with cere... |
Publication Detail:
|
Type: Comparative Study; Evaluation Studies; Journal Article |
Journal Detail:
|
Title: Cancer Volume: 116 ISSN: 0008-543X ISO Abbreviation: Cancer Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-09-27 Completed Date: 2010-11-05 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0374236 Medline TA: Cancer Country: United States |
Other Details:
|
Languages: eng Pagination: 4549-63 Citation Subset: AIM; IM |
Copyright Information:
|
Copyright © 2010 American Cancer Society. |
Affiliation:
|
MLL Munich Leukemia Laboratory, Munich, Germany. wolfgang.kern@mll-online.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antigens, CD
/
analysis Chromosome Aberrations* Cytodiagnosis Erythrocytes / immunology Flow Cytometry / methods* Granulocytes / immunology Humans Monocytes / immunology Myelodysplastic Syndromes / diagnosis*, genetics, immunology, mortality, pathology* Myeloid Cells / pathology |
| Chemical | |
Reg. No./Substance:
|
0/Antigens, CD |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Invasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcino...
Next Document: Understanding social obstacles to early breast cancer detection is critical to improving breast canc...